Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 986 | 1152 | 1180 | 1605 | 2869 |
Fund Return | 8.82% | -1.38% | 15.25% | 5.69% | 9.92% | 11.12% |
Place in category | 1652 | 1794 | 1743 | 881 | 558 | 80 |
% in Category | 94 | 98 | 99 | 60 | 48 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 7.26B | 7.71 | 4.39 | 9.76 | ||
Manulife Glbl Eq Cl Sr F | 7.26B | 8.81 | 5.68 | 11.11 | ||
Manulife Glbl Eq Cl Sr T6 | 7.26B | 7.71 | 4.39 | 9.74 | ||
Manulife Div incm Fd Sr Adv | 7.02B | 13.25 | 1.18 | 8.91 | ||
Manulife Div incm Fd Sr F | 7.02B | 14.32 | 2.32 | 10.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 14.78B | 43.16 | 12.27 | - | ||
Mawer Global Equity | 13.71B | 8.62 | 5.37 | 10.93 | ||
Capital Group Glbal Equity Fd F CAD | 13.66B | 22.86 | 3.88 | 11.66 | ||
Capital Group Glbal Equity Fd A CAD | 13.66B | 21.74 | 2.74 | 10.43 | ||
Capital Group Glbal Equity Fd D CAD | 13.66B | 22.55 | 3.53 | 11.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.27 | 102.45 | +2.14% | |
Marsh McLennan | US5717481023 | 4.96 | 227.37 | +1.31% | |
Microsoft | US5949181045 | 4.22 | 415.00 | +0.51% | |
UnitedHealth | US91324P1021 | 4.17 | 591.00 | -1.09% | |
Alimentation Couche Tard | CA01626P1484 | 3.76 | 78.58 | -0.14% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review